132 related articles for article (PubMed ID: 9408000)
1. Effect of tyrosine kinase and tyrosine phosphatase inhibitors on aortic contraction and induction of nitric oxide synthase.
Duarte J; Ocete MA; Pérez-Vizcaino F; Zarzuelo A; Tamargo J
Eur J Pharmacol; 1997 Oct; 338(1):25-33. PubMed ID: 9408000
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effects of isoflurane on protein tyrosine phosphorylation-modulated contraction of rat aortic smooth muscle.
Yu J; Ogawa K; Tokinaga Y; Mizumoto K; Kakutani T; Hatano Y
Anesthesiology; 2004 Dec; 101(6):1325-31. PubMed ID: 15564939
[TBL] [Abstract][Full Text] [Related]
3. Regulation of vascular and gastric smooth muscle contractility by pervanadate.
Laniyonu A; Saifeddine M; Ahmad S; Hollenberg MD
Br J Pharmacol; 1994 Oct; 113(2):403-10. PubMed ID: 7530569
[TBL] [Abstract][Full Text] [Related]
4. Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle.
Abebe W; Agrawal DK
J Cardiovasc Pharmacol; 1995 Jul; 26(1):153-9. PubMed ID: 7564357
[TBL] [Abstract][Full Text] [Related]
5. Effect of modulators of tyrosine kinase activity on agonist-induced contraction in the rat pulmonary vascular smooth muscle.
Savineau JP; Gonzalez De La Fuente P; Marthan R
Pulm Pharmacol; 1996 Jun; 9(3):189-95. PubMed ID: 8948516
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of isoflurane and sevoflurane on protein tyrosine phosphorylation-mediated vascular contraction.
Yu J; Mizumoto K; Kakutani T; Hasegawa A; Ogawa K; Hatano Y
Acta Anaesthesiol Scand; 2005 Jul; 49(6):852-8. PubMed ID: 15954971
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of inducible nitric oxide synthase by geldanamycin, a tyrosine kinase inhibitor, in endothelial, smooth muscle cells, and in rat aorta.
Joly GA; Ayres M; Kilbourn RG
FEBS Lett; 1997 Feb; 403(1):40-4. PubMed ID: 9038357
[TBL] [Abstract][Full Text] [Related]
8. Multiple effects of tyrosine kinase inhibitors on vascular smooth muscle contraction.
Filipeanu CM; Brailoiu E; Huhurez G; Slatineanu S; Baltatu O; Branisteanu DD
Eur J Pharmacol; 1995 Jul; 281(1):29-35. PubMed ID: 8566113
[TBL] [Abstract][Full Text] [Related]
9. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein-ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
Eur J Pharmacol; 1997 Jun; 329(2-3):137-46. PubMed ID: 9226406
[TBL] [Abstract][Full Text] [Related]
10. Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase.
Watts SW; Yeum CH; Campbell G; Webb RC
J Vasc Res; 1996; 33(4):288-98. PubMed ID: 8695753
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
Joly GA; Narayanan K; Griffith OW; Kilbourn RG
Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor inhibits vascular contraction to 5-hydroxytryptamine: involvement of tyrosine phosphatase.
Melis A; Watts SW; Florian J; Klarr S; Webb RC
Gen Pharmacol; 2000 Feb; 34(2):137-45. PubMed ID: 10974421
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidylcholine potentiates vascular contractile responses in rat aorta via activation of tyrosine kinase.
Suenaga H; Kamata K
Br J Pharmacol; 2002 Feb; 135(3):789-99. PubMed ID: 11834627
[TBL] [Abstract][Full Text] [Related]
14. Induction of nitric oxide synthase by endotoxin in rat isolated aorta but not in rat aortic smooth muscle cells grown in culture from explant.
McKendrick JD; Paisley K; Eason S; Mian KB; Martin W
Arch Int Pharmacodyn Ther; 1995; 330(2):206-24. PubMed ID: 8861713
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta, Src- and non-Src tyrosine kinases, and nitric oxide synthase induction in rat aorta in vitro.
Gui Y; Zheng XL; Hollenberg MD
Am J Physiol Heart Circ Physiol; 2000 Aug; 279(2):H566-76. PubMed ID: 10924055
[TBL] [Abstract][Full Text] [Related]
16. Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine.
Scott JA; Machoun M; McCormack DG
J Appl Physiol (1985); 1996 Jan; 80(1):271-7. PubMed ID: 8847314
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of tyrosine kinase in the LPS-promoted initiation of L-arginine-induced relaxation of rat aorta mediated by induction of no synthase.
Moritoki H; Hisayama T; Takeuchi S; Kondoh W; Takeji Y
Life Sci; 1995; 57(11):PL125-30. PubMed ID: 7544862
[TBL] [Abstract][Full Text] [Related]
18. Aminoguanidine selectively decreases cyclic GMP levels produced by inducible nitric oxide synthase.
Griffiths MJ; Messent M; Curzen NP; Evans TW
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1599-604. PubMed ID: 7582301
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
20. Low extracellular Mg2+ contraction of arterial muscle: role of protein kinase C and protein tyrosine phosphorylation.
Yang ZW; Altura BT; Altura BM
Eur J Pharmacol; 1999 Aug; 378(3):273-81. PubMed ID: 10493103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
